[1]
“Pediatric use of anthracyclines and cardiotoxicity: Review of new screening methods and therapy regarding a clinical case”, Rev Port Oncol, vol. 3, no. 1, pp. 28–31, Mar. 2020, doi: 10.57678/rpo.8.